Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
951
-
Total 13F shares, excl. options
-
41,655,838
-
Shares change
-
-2,284,802
-
Total reported value, excl. options
-
$6,352,062,969
-
Value change
-
-$354,862,874
-
Put/Call ratio
-
83.2%
-
Number of buys
-
392
-
Number of sells
-
-315
-
Price
-
$152.62
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2021
1,070 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q4 2021.
ISHARES TR - ISHARES BIOTECH (IBB) has 951 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41,655,838 shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (11,668,854 shares), MORGAN STANLEY (3,799,844 shares), UBS Group AG (1,859,453 shares), CITIGROUP INC (1,597,087 shares), ROYAL BANK OF CANADA (1,340,255 shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (1,311,700 shares), BNP PARIBAS ARBITRAGE, SA (1,282,280 shares), GOLDMAN SACHS GROUP INC (1,172,739 shares), WELLS FARGO & COMPANY/MN (711,889 shares), and COMMERCE BANK (583,506 shares).
This table shows the top 951 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.